Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02951455 · ClinicalTrials.gov registry record · NA
Community Wise: An Innovative Multi-level Intervention to Reduce Alcohol and Illegal Drug Use
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 602
- Enrollment target
NCT02951455: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.
NCT02951455 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 602 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02951455, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 602 participants
- Enrollment target
Study Summary
The current project seeks to implement the Multiphase Optimization Strategy (MOST) and Community Based Participatory Research (CBPR) principles to identify the most efficient, scalable, and sustainable combination of Community Wise components. Community Wise is a manualized multi-level intervention aimed at reducing health inequalities related to alcohol and illicit drug use (AIDU).This 2x2x2x2 factorial design will be fully powered to detect change in AIDU in a sample of 528 men with substance use disorders and a history of incarceration residing in distressed communities with predominantly Black populations. Participants will be randomly assigned to one of sixteen experimental conditions.
Primary Outcome
The primary outcome was the percentage of ASM (i.e., the percentage of days each substance was used in the past month) as operationalized by the Global Assessment of Individual needs. At each time point (baseline, five follow-ups), percentage ASM was calculated by dividing the reported number of days in the past month that participants used cannabis, heroin, alcohol, opioids, or cocaine by the number of days in the month (data were collected with the Timeline Follow-Back measure), multiplied by
Interventions
- BEHAVIORAL Critical Dialogue
- BEHAVIORAL Capacity Building Project
- BEHAVIORAL Quality of Life Wheel
- BEHAVIORAL PF
- BEHAVIORAL LC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2017-01-17 |
| Est. Completion | 2020-01-20 |
| Phase | NA |
What the finished NCT02951455 record still lists
NCT02951455 is an interventional study that assigns participants to a tested intervention. The registered 602 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 5 interventions - of which Critical Dialogue is the first listed.
NCT02951455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02951455 about?
NCT02951455 is a clinical study titled "Community Wise: An Innovative Multi-level Intervention to Reduce Alcohol and Illegal Drug Use". The current project seeks to implement the Multiphase Optimization Strategy (MOST) and Community Based Participatory Research (CBPR) principles to identify the most efficient, scalable, and sustainable combination of Community Wise components. Community Wise is a manualized multi-level intervention ...
What is the current status of trial NCT02951455?
This trial is currently completed. It is a NA study. The enrollment target is 602 participants. The study started on 2017-01-17. Estimated completion is 2020-01-20.
What interventions are being tested in trial NCT02951455?
The interventions under investigation include: Critical Dialogue (BEHAVIORAL), Capacity Building Project (BEHAVIORAL), Quality of Life Wheel (BEHAVIORAL), PF (BEHAVIORAL), LC (BEHAVIORAL).
Who is sponsoring clinical trial NCT02951455?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02951455's enrollment target sits among peer trials
602 162nd of 2000 higher than 1,839 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI